GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 205 filers reported holding GENMAB A/S in Q3 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,857 | -58.2% | 81 | -55.0% | 0.00% | – |
| Q2 2023 | $6,842 | +66.2% | 180 | +65.1% | 0.00% | – |
| Q1 2023 | $4,116 | -11.7% | 109 | -0.9% | 0.00% | – |
| Q4 2022 | $4,662 | – | 110 | +1000.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 10 | -99.8% | 0.00% | – |
| Q4 2021 | $224,000 | +4380.0% | 5,652 | +4814.8% | 0.00% | – |
| Q3 2021 | $5,000 | +150.0% | 115 | +94.9% | 0.00% | – |
| Q1 2021 | $2,000 | – | 59 | +637.5% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 8 | -95.2% | 0.00% | – |
| Q3 2020 | $6,000 | +500.0% | 165 | +251.1% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 47 | -30.9% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 68 | -20.9% | 0.00% | – |
| Q3 2019 | $2,000 | – | 86 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |